Drug · DIN 02425629
LUCENTIS
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 18, 2014; first marketed September 18, 2014.
- Drug Identification Number (DIN)
- 02425629
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Intravitreal
- Therapeutic class (ATC)
- Ranibizumab S01LA04
- Class
- Human
- Record last updated
- July 31, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RANIBIZUMAB | 10 MG | ML |
Other DINs named LUCENTIS
- DIN 02296810 · Marketed